Pfizer’s announcement comes ahead of the Trump administration’s long-awaited bill to lower taxes.
Pfizer said on Monday its board had authorized a new $10 billion share repurchase program and raised its quarterly dividend.
Pfizer’s announcement comes ahead of the Trump administration’s long-awaited bill to lower taxes. The bill, which looks set to be passed into a law, will overhaul the country’s tax system for the first time in more than 30 years.
